SEHA Sheikh Khalifa Medical City (SKMC) Market Research Report

Background

Overview

SEHA Sheikh Khalifa Medical City (SKMC) is a leading healthcare institution located in Abu Dhabi, United Arab Emirates. As the flagship tertiary hospital and the largest teaching medical center in the Emirate, SKMC offers a comprehensive range of medical services to the community. The facility comprises a 441-bed acute care hospital, 16 outpatient specialty clinics, and a dedicated 125-bed Behavioral Sciences Pavilion.

Mission and Vision

• Mission: To provide compassionate, patient-centered care of the highest quality, in a setting of education and research.

• Vision: To be recognized as a preeminent medical center that strives to provide outstanding patient experience, superior clinical outcomes, and an improved quality of life for the people it serves.

Primary Area of Focus

SKMC focuses on delivering integrated healthcare services across various specialties, including pediatrics, cardiac sciences, surgery, and behavioral health. The institution is committed to advancing medical care through education, research, and the implementation of innovative technologies.

Industry Significance

As part of the Abu Dhabi Health Services Company (SEHA), SKMC plays a pivotal role in the UAE's healthcare sector. It serves as a center of excellence, setting benchmarks for quality care and medical innovation in the region.

Key Strategic Focus

Core Objectives

• To provide high-quality, patient-centered care across a wide range of medical specialties.

• To advance medical research and education, fostering a culture of continuous improvement.

• To implement innovative technologies and practices that enhance patient outcomes and operational efficiency.

Specific Areas of Specialization

• Pediatrics: Offering comprehensive services, including the largest pediatric critical care unit and emergency department in the UAE.

• Cardiac Sciences: Home to the largest pediatric heart program in the region and the only pediatric cardiac surgery program in Abu Dhabi.

• Transplant Services: Established the UAE's first and most comprehensive kidney transplant center, providing both adult and pediatric services.

Key Technologies Utilized

• State-of-the-art medical equipment and facilities to support advanced diagnostics and treatments.

• Implementation of electronic health records (EHR) systems to streamline patient care and data management.

• Adoption of telemedicine services to enhance accessibility and convenience for patients.

Primary Markets and Conditions Targeted

• Residents of Abu Dhabi and the broader UAE community seeking specialized medical care.

• Patients requiring advanced pediatric and adult medical services, including complex surgeries and transplant procedures.

Financials and Funding

Funding History

As a public healthcare institution under SEHA, SKMC's funding is primarily sourced from the UAE government. Specific details regarding total funds raised and recent funding rounds are not publicly disclosed.

Notable Investors

Being a government-funded entity, SKMC does not have external investors. Its financial resources are allocated by the UAE government to support its operations and development.

Intended Utilization of Capital

• Expansion and enhancement of medical facilities and services.

• Investment in advanced medical technologies and equipment.

• Support for research and educational initiatives to advance medical knowledge and practice.

Pipeline Development

Key Pipeline Candidates

SKMC is continually developing and expanding its medical services, particularly in the following areas:

• Pediatric Cardiac Care: Enhancing capabilities to perform complex congenital heart surgeries and treatments.

• Transplant Services: Expanding kidney and liver transplant programs to meet growing demand.

• Behavioral Health: Developing comprehensive mental health services for both adults and children.

Stages of Clinical Trials or Product Development

While specific details on ongoing clinical trials are not publicly available, SKMC is involved in various research initiatives aimed at improving patient care and treatment outcomes.

Target Conditions

• Congenital and acquired heart conditions in pediatric patients.

• Chronic kidney disease and end-stage renal failure.

• Mental health disorders, including depression, anxiety, and behavioral issues in children.

Relevant Timelines for Anticipated Milestones

Specific timelines for upcoming milestones are not publicly disclosed. However, SKMC continues to enhance its services and facilities to meet the evolving healthcare needs of the community.

Technological Platform and Innovation

Proprietary Technologies

SKMC utilizes advanced medical technologies and equipment to provide high-quality care. While specific proprietary technologies are not detailed, the institution is committed to integrating cutting-edge solutions into its healthcare delivery.

Significant Scientific Methods

• Clinical Pathways: Standardized protocols to ensure evidence-based and efficient patient care.

• Patient Safety Initiatives: Implementing strategies to minimize medical errors and enhance patient safety.

• Quality Improvement Programs: Continuous assessment and refinement of healthcare services to improve outcomes.

AI-Driven Capabilities

While specific AI applications are not detailed, SKMC is likely exploring the integration of artificial intelligence in areas such as diagnostic imaging, predictive analytics for patient outcomes, and operational efficiencies.

Leadership Team

Key Executive Profiles

• Bader Al Qubaisi: Chief Executive Officer (CEO) of SKMC. With 19 years of professional experience, Mr. Al Qubaisi has played a pivotal role in reactivating key services and expanding business opportunities at SKMC, leading to improved financial performance. Prior to his role as CEO, he served as SEHA's Group Chief Information Officer, contributing significantly to technology advancement projects and process streamlining across various departments.